Clostridium difficile infection among veterans health administration patients

Infection Control and Hospital Epidemiology

Volumn 36, Issue 9, 2015, Pages 1038-1045

  Young Xu, Yinong ^a,b   Kuntz, Jennifer L ^c   Gerding, Dale N ^d,e   Neily, Julia ^a   Mills, Peter ^a,b   Dubberke, Erik R ^f   Olsen, Margaret A ^f   Kelly, Ciarán P ^g   Mahé, Cédric ^h  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d HINES VA HOSPITAL   (United States)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; CLOSTRIDIUM DIFFICILE INFECTION; DESCRIPTIVE RESEARCH; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE MANAGEMENT; HOSPITAL CARE; HOSPITALIZATION; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT CARE; PREVALENCE; RETROSPECTIVE STUDY; VETERANS HEALTH; ADOLESCENT; AMBULATORY CARE; CROSS INFECTION; ELECTRONIC HEALTH RECORD; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GOVERNMENT; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; ELECTRONIC HEALTH RECORDS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; YOUNG ADULT;

EID: 84958541372     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2015.138     Document Type: Article

References (24)

1. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009;7:526–536.
2. Koo HL, Garey KW, DuPont HL. Future novel therapeutic agents for Clostridium difficile infection. Expert Opin Investig Drugs 2010;19:825–836.
3. Kelly CP, LaMont JT. Clostridium difficile—more difficult than ever. N Engl J Med 2008;359:1932–1940.
4. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the Healthcare System. Clin Infect Dis 2012;55:S88–S92.
5. Centers for Disease Control and Prevention. QuickStats: rates of Clostridium difficile infection among hospitalized patients aged ≥65 years, by age group—National Hospital Discharge Survey, United States, 1996–2009. MMWR Morb Mortal Wkly 2011; 60:1171.
6. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000;342:390.
7. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204.
8. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007;45:992.
9. Armbruster S, Goldkind L. A 5-year retrospective review of experience with Clostridium difficile-associated diarrhea. Mil Med 2012;177:456–459.
10. Jump RL, Olds DM, Jury LA, et al. Specialty care delivery: bringing infectious disease expertise to the residents of a Veterans Affairs long-term care facility. J Am Geriatr Soc 2013;61:782–787.
11. Bajaj JS, Ratliff SM, Heuman DM, Lapane KL. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis. Aliment Pharmacol Ther 2012;36:866–874.
12. Huttner B, Jones M, Rubin MA, et al. Double trouble: how big a problem is redundant anaerobic antibiotic coverage in Veterans Affairsmedical centers? J Antimicrob Chemother 2012;67:1537–1539.
13. McFarland LV, Clarridge JE, Beneda HW, Raugi GJ. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. Clin Infect Dis 2007;45:1141–1151.
14. Donskey CJ, Sunkesula VC, Jencson AL, et al. Utility of a commercial PCR assay and a clinical prediction rule for detection of toxigenic Clostridium difficile in asymptomatic carriers. J Clin Microbiol 2014;52:315–318.
15. Graber CJ, Madaras-Kelly K, Jones MM, Neuhauser MM, Goetz MB. Unnecessary antimicrobial use in the context of Clostridium difficile infection: a call to arms for the Veterans Affairs Antimicrobial Stewardship Task Force. Infect Control Hosp Epidemiol 2013;34:651–653.
16. Balbale SN, Johnson S, Burns SP, et al. Community-associated Clostridium difficile infection among veterans with spinal cord injury and disorder. Infect ControlHosp Epidemiol 2014;35:577–580.
17. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol, 28: 140–145.
18. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431–455.
19. Evans ME. Clostridium difficile infections in Veterans Health Administration acute care facilities. Infect Control Hosp Epidemiol 2014;35:1037–1042.
20. Gould CV, Edwards JR, Cohen J, et al. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis 2013;57:1304–1307.
21. Chitnis AS, Holzbauer SM, Belflower RM, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med 2013;173:1359–1367.
22. Goto M, Ohl ME, Schweizer ML, Perencevich EN. Accuracy of administrative code data for the surveillance of healthcare-associated infections: a systematic review and meta-analysis. Clin Infect Dis 2014; Mar 58:688–696.
23. Jain R, Kralovic SM, Evans ME, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011;364:1419–1430.
24. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015;372: 825–834.